License procedures concerning manufacture of OTCs eased

The Korea Food and Drug Administration announced recently that a series of measures designed to expand the number of OTC products will be adopted via drug-related reforms including re-evaluation of drugs.

The KFDA said that the measures are part of the government's efforts to boost the manufacture of OTCs, saying that the domestic OTC market structure is extremely vulnerable due to more stri...